Drug firms call on FDA to add to guidance on trial enrichment

03/25/2013 | OutSourcing-Pharma.com

Large drug firms including Merck & Co., Eli Lilly and Co. and Pfizer urged the FDA to bolster its draft guidance on enrichment measures for clinical trials with additional examples involving various therapeutic areas. Pharmaceutical companies also called for increased guidance involving diagnostics.

View Full Article in:

OutSourcing-Pharma.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ